|Articles|September 1, 2003
CXRs offer 'Limited Value' for Melanoma
Author(s)Beth Kapes
Chicago - A recent review of routine chest X-rays for pulmonary metastasis adds weight to a growing body of evidence that CXRs have limited value in the follow-up of melanoma patients and their prolonged survival.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
2
Transformative Advances This Year and Beyond
3
KT-621 Produces 98% STAT6 Degradation in AD Patients
4
Site-Specific MED Variability Guides 308-nm Excimer Laser Dosing
5















